UPB · Categories · Form 4
UPB - SEC Form 4 insider transactions
Upstream Bio Inc. (UPB) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for UPB
- CFO and COO Gray Michael sold $7,915 worth of shares (852 units at $9.29), decreasing direct ownership by 3% to 29,648 units (SEC Form 4)4 - Upstream Bio, Inc. (0002022626) (Issuer)
- Chief Medical Officer Deykin Aaron sold $8,305 worth of shares (894 units at $9.29), decreasing direct ownership by 3% to 32,687 units (SEC Form 4)4 - Upstream Bio, Inc. (0002022626) (Issuer)
- Chief Executive Officer Sutherland Everett Rand sold $19,444 worth of shares (2,093 units at $9.29), decreasing direct ownership by 3% to 72,907 units (SEC Form 4)4 - Upstream Bio, Inc. (0002022626) (Issuer)
- General Counsel Ambrose Allison sold $4,413 worth of shares (475 units at $9.29), decreasing direct ownership by 3% to 16,525 units (SEC Form 4)4 - Upstream Bio, Inc. (0002022626) (Issuer)
- Chief Business Officer Houghton Adam sold $6,494 worth of shares (699 units at $9.29), decreasing direct ownership by 3% to 24,301 units (SEC Form 4)4 - Upstream Bio, Inc. (0002022626) (Issuer)
- Chief Business Officer Houghton Adam was granted 25,000 shares (SEC Form 4)4 - Upstream Bio, Inc. (0002022626) (Issuer)
- Chief Medical Officer Deykin Aaron was granted 32,000 shares, increasing direct ownership by 2,024% to 33,581 units (SEC Form 4)4 - Upstream Bio, Inc. (0002022626) (Issuer)
- General Counsel Ambrose Allison was granted 17,000 shares (SEC Form 4)4 - Upstream Bio, Inc. (0002022626) (Issuer)
- CFO and COO Gray Michael was granted 30,500 shares (SEC Form 4)4 - Upstream Bio, Inc. (0002022626) (Issuer)
- Chief Executive Officer Sutherland Everett Rand was granted 75,000 shares (SEC Form 4)4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Director Renaud Ronald C Jr4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Director Ruddy Marcella K.4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Director Chimovits Erez4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Director Fleming Harold Edward4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Director Beckman Daniella4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Director Ratcliffe Liam4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Sutherland Everett Rand4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by CFO and COO Gray Michael4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Chief Business Officer Houghton Adam4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Deykin Aaron4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by General Counsel Ambrose Allison4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by General Counsel Ambrose Allison4 - Upstream Bio, Inc. (0002022626) (Issuer)
- Large owner Wellington Biomedical Innovation Master Investors (Cayman) Ii L.P. converted options into 894,733 shares (SEC Form 4)4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Director Renaud Ronald C Jr4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Director Ratcliffe Liam4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Director Ruddy Marcella K.4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Director Beckman Daniella4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Director Fleming Harold Edward4 - Upstream Bio, Inc. (0002022626) (Issuer)
- SEC Form 4 filed by Director Chimovits Erez4 - Upstream Bio, Inc. (0002022626) (Issuer)